You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preoperative chemoradiation

Showing 1 - 25 of 5,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Rectum Trial in New Brunswick (combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI

Recruiting
  • Cancer of Rectum
  • combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil)
  • Lakewood, New Jersey
  • +4 more
Nov 2, 2022

Rectal Cancer Trial in Orange, Detroit, Saint Louis (Epacadostat, Tumor biopsy, Peripheral blood draw)

Recruiting
  • Rectal Cancer
  • Orange, California
  • +2 more
Jul 6, 2022

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Rectal Tumors Trial in Guangzhou (Oxaliplatin, capecitabine, Radiation)

Active, not recruiting
  • Rectal Neoplasms
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Jul 26, 2022

Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional

Withdrawn
  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Aerobic Exercise
  • +5 more
  • (no location specified)
Oct 26, 2022

Esophageal Squamous Cell Carcinoma, Patient-reported Outcomes, Immunotherapy Trial in Guangzhou (drug, radiation, procedure)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Nov 24, 2022

Radiogenomics in Advanced Rectal Cancer

Recruiting
  • Rectal Cancer
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Sep 2, 2021

    Pancreatic Cancer Trial in Houston (Gemcitabine)

    Terminated
    Has Results
    • Pancreatic Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 15, 2020

    Rectal Tumors Trial in Beijing (SCPRT plus neoadjuvant chemo, long course chemoradiation)

    Recruiting
    • Rectal Neoplasms
    • SCPRT plus neoadjuvant chemotherapy
    • long course chemoradiation
    • Beijing, China
      Department of Radiation Oncology, Cancer Institute and Hospital,
    Sep 1, 2021

    Rectal Cancer Trial in Seoul (Temozolomide)

    Completed
    Has Results
    • Rectal Cancer
    • Seoul, Songpa-gu, Korea, Republic of
      Asan Medical Center
    Jan 17, 2021

    Sinonasal Carcinoma Trial (drug, procedure, other)

    Not yet recruiting
    • Sinonasal Carcinoma
    • (no location specified)
    Dec 9, 2021

    Esophageal Cancer, Adenocarcinoma, Esophageal, Adenocarcinoma, Gastroesophageal Junction Trial in Winnipeg, London, Toronto

    Recruiting
    • Esophageal Cancer
    • +2 more
    • (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
    • Carboplatin paclitaxel plus concurrent radiotherapy
    • Winnipeg, Manitoba, Canada
    • +2 more
    Mar 29, 2021

    Lymph Node Ratio and Survival Rate in Preoperative

    Completed
    • Rectal Cancer
      • Bangkok, Bankok, Thailand
        Chairat Supsamutchai
      May 7, 2020

      Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab Injection)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Pembrolizumab Injection
      • Shanghai, Shanghai, China
      • +1 more
      Aug 29, 2021

      Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

      Recruiting
      • Epstein-Barr Virus Positive
      • +10 more
      • Atlanta, Georgia
      • +2 more
      Dec 10, 2022

      Gastrointestinal Cancer Trial in Houston (Oxaliplatin, Capecitabine, Leucovorin)

      Terminated
      Has Results
      • Gastrointestinal Cancer
      • Houston, Texas
      • +3 more
      Oct 9, 2020

      Pre-op Chemoradiation in Resectable Rectal Cancer:Pilot Study

      Completed
      • Rectal Carcinoma
        • Chapel Hill, North Carolina
          University of North Carolina-Chapel Hill
        Jan 27, 2021

        Esophagogastric Junction Disorder, Tumors Trial (chemoradiation with weekly 5Fu and oxaliplatin, Perioperative mFLOT,

        Not yet recruiting
        • Esophagogastric Junction Disorder
        • Neoplasms
        • chemoradiation with weekly 5Fu and oxaliplatin
        • +2 more
        • (no location specified)
        Dec 19, 2019

        Predictive Factor of Pathologic Complete Response After

        Completed
        • Rectum Cancer
          • Bangkok, Bankok, Thailand
            Chairat Supsamutchai
          May 15, 2022

          Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in Portland (drug, radiation, other, procedure)

          Active, not recruiting
          Has Results
          • Pancreatic Adenocarcinoma
          • Resectable Pancreatic Carcinoma
          • Portland, Oregon
            OHSU Knight Cancer Institute
          Sep 2, 2021

          Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab)

          Unknown status
          • Esophageal Squamous Cell Carcinoma
          • Shanghai, Shanghai, China
            Ruijin Hospital, Shanghai JiaoTong University School of Medicine
          May 31, 2020

          Stomach Tumor, GastroEsophageal Cancer, Adenocarcinoma Trial in Shanghai (drug, radiation, procedure)

          Recruiting
          • Stomach Neoplasm
          • +4 more
          • Tegafur-Gimeracil-Oteracil Potassium
          • +3 more
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cancer Center
          Jul 2, 2020

          Rectal Tumors Malignant Trial in Beijing (radiation, drug, procedure)

          Completed
          • Rectal Neoplasms Malignant
          • Preoperative radiation
          • +2 more
          • Beijing, Beijing, China
            Department of Radiation Oncology, Cancer Institute and Hospital,
          Sep 1, 2021

          Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

          Active, not recruiting
          • Esophageal Carcinoma
          • Rochester, New York
            University of Rochester
          Aug 17, 2022

          RECTAL CANCER Trial in Faenza (Capecitabine, Radiotherapy, Durvalumab)

          Recruiting
          • RECTAL CANCER
          • Faenza, Italy
            Ospedale Degli Infermi Uo Oncologia
          Jul 19, 2022